Back to Top Skip to main content

Meeting Date: November 19-20, 2014

Download the UF BPA TemplateDownload the UF VARR Template

Information for Pharmaceutical Manufacturers

Price & Refund Quotes
Due Date 
Posted Date  Drug Class/Subclass/Route Utilization  UF BPA Appendix  UF VARR Appendix
October 3, 2014 August 28, 2014 Pulmonary Arterial Hypertension Industry Report UF BPA Appendix UF VARR Appendix
October 3, 2014  August 28, 2014 Mulitple Sclerosis Agents Industry Report UF BPA Appendix UF VARR Appendix
October 17, 2014  September 17, 2014 Self Monitoring Blood Glucose Strips Industry Report UF BPA Appendix UF VARR Appendix
October 3, 2014  August 28, 2014  Anoro Ellipta Industy Report UF BPA Appendix UF VARR Appendix
October 3, 2014  August 28, 2014  Prolensa Industry Report UF BPA Appendix UF VARR Appendix
October 3, 2014  August 28, 2014 Simbrinza Industry Report UF BPA Appendix UF VARR Appendix
October 3, 2014  August 28, 2014 V-Go Industry Report UF BPA Appendix UF VARR Appendix

Notes:

For Self Monitoring Blood Glucose Strips only:

For other products under review:

  • To request a date/time for clinical presentation appointment, call 1-210-295-1271.
  • Clinical presentations MUST be made available on CD (not to be retained by PEC-B staff) at time of presentation. Flash drives are not authorized. PEC Branch Industry Liaison: Call 1-210-295-2773

Teleconference Notice

November 2014 DoD P&T Meeting Reviews

The teleconference will be held September 3, 2014, 10:30 AM Central Time.

The teleconference will review the quoting process and to address industry questions about these reviews. Interested manufacturers must register by submitting participant's name, company name, and the drug class your product is assigned and any advance questions. Call 1-303-676-3529 no later than September 2, 2014. Advance questions will be addressed during the teleconference.

The call-in number and a pre-conference agenda will be emailed to all registered participants. A summary of the teleconference, to include all questions and answers, will be posted at this site following the teleconference.

For Self Monitoring Blood Glucose Test Strips only: An industry/Government pre-proposal teleconference will not be held. 

Bid Submission Steps:

Step 1: Download Utilization.

Step 2: Download and complete the UF BPA and VARR template and applicable appendix.

Step 3: Send original signed quotes to:

Pharmacy Contracting Officer/COD
DoD Uniform Formulary BPA
Defense Health Agency
16401 East Centretech Parkway
Aurora, CO 80011-9043

UF BPA Quotes:

Pharmaceutical companies may submit UF BPA price quotes for pharmaceutical agents in the classes under review that will be used by the DoD P&T Committee as the cost to the government portion of its relative cost effectiveness considerations under 32 CFR 199.21.

The original signed UF BPA quote and e-mail containing the duplicate in Adobe PDF file format must be received by 1:00 PM EST of the date specified above. Quotes received after the deadline may be rejected by the Contracting Officer. All original quotes must contain original signatures. The original signed quote and the electronic duplicate must be identical in every aspect.

The establishment of a UF BPA with a pharmaceutical company for a generic (multi-source) pharmaceutical agent does not establish that pharmaceutical company as the sole source of supply for the pharmaceutical agent. However, in the event of existing Joint DoD/VA contracts, UF BPA quotes will not be accepted for generic (multi-source) pharmaceutical agents.

UF VARR Quotes:

Pharmaceutical companies may submit Uniform Formulary Voluntary Agreements for TRICARE Retail Pharmacy Refunds (UF VARR) quotes for pharmaceutical agents in the classes under review that will be used by the DoD P&T Committee as the cost to the government portion of its relative cost effectiveness considerations under 32 CFR 199.21.

The original signed UF VARR quote and e-mail containing the duplicate in Adobe PDF file format must be received by 1:00 PM EST of the date specified above. Quotes received after the deadline may be rejected by the Contracting Officer. All original quotes must contain original signatures. The original signed quote and the electronic duplicate must be identical in every aspect.

UF VARR quotes will not be accepted for generic (multi-source) pharmaceutical agents.

NOTICE

For some drug classes, DoD may require companies to submit multiple price and refund quotes contingent upon the number of agents selected to the Uniform Formulary (UF) or Basic Core FormularyThe Basic Core Formulary (BCF) is a list of medications required to be on formulary at all full-service military treatment facilities (MTFs). BCF medications are intended to meet the majority of the primary care needs of DoD beneficiaries.Basic Core Formulary (BCF) as defined by the government. Please read carefully the information about submitting multiple quotes in the UF Price and Refund Information, the applicable 'Drug Class Pages' that are linked to the Drug Classes Under Review page, the UF BPA Price Quote Template, and the UF VARR Refund Quote Template. Please use the contact Information below for additional questions.

General (all reviews)

The DoD reserves the right to exclude specific formulations or NDCs of a given drug from a submitted UF BPA and/or UF VARR based on recommendations from the P&T Committee and decision of the Director, DHA.

For additional questions, please call 1-303-676-3529.

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.